YU33970B - Process for preparing 2-bromo-delta-ergocryptine - Google Patents

Process for preparing 2-bromo-delta-ergocryptine

Info

Publication number
YU33970B
YU33970B YU1336/69A YU133669A YU33970B YU 33970 B YU33970 B YU 33970B YU 1336/69 A YU1336/69 A YU 1336/69A YU 133669 A YU133669 A YU 133669A YU 33970 B YU33970 B YU 33970B
Authority
YU
Yugoslavia
Prior art keywords
ergocryptine
bromo
delta
preparing
Prior art date
Application number
YU1336/69A
Other languages
English (en)
Other versions
YU133669A (en
Inventor
Fluckiger Edward
Edward Fluckiger
Troxler Franz
Franz Troxler
Hofmann Albert
Albert Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of YU133669A publication Critical patent/YU133669A/xx
Publication of YU33970B publication Critical patent/YU33970B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
YU1336/69A 1968-05-31 1969-05-29 Process for preparing 2-bromo-delta-ergocryptine YU33970B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH816868A CH507249A (de) 1968-05-31 1968-05-31 Verfahren zur Herstellung von 2-Brom-a-ergokryptin

Publications (2)

Publication Number Publication Date
YU133669A YU133669A (en) 1978-02-28
YU33970B true YU33970B (en) 1978-09-08

Family

ID=4336202

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1336/69A YU33970B (en) 1968-05-31 1969-05-29 Process for preparing 2-bromo-delta-ergocryptine

Country Status (19)

Country Link
US (2) US3752814A (fr)
AT (1) AT301765B (fr)
BE (1) BE733799A (fr)
BR (1) BR6909341D0 (fr)
CA (1) CA953720A (fr)
CH (1) CH507249A (fr)
CS (1) CS163736B2 (fr)
CY (1) CY780A (fr)
DE (1) DE1926045C3 (fr)
DK (1) DK124884B (fr)
FI (1) FI49035C (fr)
FR (1) FR2009737A1 (fr)
GB (1) GB1257841A (fr)
IT (1) IT7827515A0 (fr)
MY (1) MY7500028A (fr)
NL (1) NL151374B (fr)
PL (1) PL80058B1 (fr)
SE (1) SE341854B (fr)
YU (1) YU33970B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU39786B (en) * 1976-12-23 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-alfa-ergocriptine
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
YU39849B (en) * 1978-09-26 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
JPS606815A (ja) * 1983-06-24 1985-01-14 Mitsutoyo Mfg Co Ltd 微動送り装置
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
EP0462189B1 (fr) * 1989-03-10 1995-09-27 Endorecherche Inc. Therapie combinee pour le traitement de maladies sensibles a l'oestrogene
CA2030174C (fr) * 1990-01-10 1996-12-24 Anthony H. Cincotta Procede pour la reduction a long terme des reserves lipidiques, de l'insulinoresistance, de l'hyperinsulinemie et de l'hypoglycemie chez les vertebres
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5817751A (en) * 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
DK0910365T3 (da) * 1996-05-01 2003-10-20 Harvard College Væksthæmning og udslettelse af faste tumorer ved at anvende en prolactinmodulator og en fotosensibilisator
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
US5874589A (en) * 1997-07-18 1999-02-23 Glaxo Wellcome, Inc. Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
ATE439347T1 (de) * 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
WO2006099877A1 (fr) * 2005-03-24 2006-09-28 Atef Mohammed Mostafa Darwish Suppositoires rectaux et vaginaux contenant de la bromocriptine et un poloxamere bioadhesifs
JP2009503050A (ja) * 2005-08-04 2009-01-29 ファイザー・リミテッド ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AU2007219236B2 (en) * 2006-02-23 2012-06-21 Pfizer Limited Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
JP2010509392A (ja) 2006-11-13 2010-03-25 ファイザー・プロダクツ・インク ジアリール、ジピリジニルおよびアリール−ピリジニル誘導体ならびにその使用
JP2010510201A (ja) * 2006-11-20 2010-04-02 グレンマーク・ファーマシューティカルズ・エスエー ステアリン酸ＣｏＡ脱飽和酵素阻害剤としてのアセチレン誘導体
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2009037542A2 (fr) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Composés spirocycliques en tant qu'inhibiteurs de stéaroyle coa désaturase
JP5328244B2 (ja) * 2008-07-07 2013-10-30 株式会社ニュージェン・ファーマ 筋萎縮性側索硬化症治療剤
DK2326638T5 (da) * 2008-08-06 2014-01-13 Pfizer Ltd Diazepin- og diazocan-forbindelser som mc4-agonister
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
US9585885B2 (en) 2012-12-10 2017-03-07 Kissei Pharmaceutical Co., Ltd. Substituted pyrido[2,3-g]quinazolines as dopamine D2 receptor agonists
ES2897475T3 (es) * 2016-04-20 2022-03-01 Veroscience Llc Composición y método para el tratamiento de trastornos metabólicos
CA3068575A1 (fr) 2017-06-28 2019-01-03 Kyoto University Agent pour la prevention et/ou le traitement de la maladie d'alzheimer
WO2019079623A1 (fr) 2017-10-18 2019-04-25 Veroscience Llc Formulations de bromocriptine améliorées

Also Published As

Publication number Publication date
BR6909341D0 (pt) 1973-02-08
FR2009737A1 (fr) 1970-02-06
IT7827515A0 (it) 1978-09-11
GB1257841A (fr) 1971-12-22
US3752888A (en) 1973-08-14
FI49035B (fr) 1974-12-02
DE1926045A1 (de) 1969-12-04
DE1926045C3 (de) 1978-09-21
YU133669A (en) 1978-02-28
NL151374B (nl) 1976-11-15
PL80058B1 (fr) 1975-08-30
SE341854B (fr) 1972-01-17
US3752814A (en) 1973-08-14
AT301765B (de) 1972-09-25
FI49035C (fi) 1975-03-10
DE1926045B2 (de) 1978-01-12
CY780A (en) 1975-03-01
NL6907038A (fr) 1969-12-02
CA953720A (en) 1974-08-27
CS163736B2 (fr) 1975-11-07
BE733799A (fr) 1969-12-01
MY7500028A (en) 1975-12-31
DK124884B (da) 1972-12-04
CH507249A (de) 1971-05-15

Similar Documents

Publication Publication Date Title
YU133669A (en) Process for preparing 2-bromo-alfa-ergocryptine
YU169669A (en) Process for preparing delta-aminocyclohexadienyl alkylene-penicillin
YU314669A (en) Process for preparing phenylethanolamines
YU36516B (en) Process for obtaining substituted 3-alkoxy-thianaphthene-2-carboxamides
IL32243A (en) Process for preparing quinoxaline-di-n-oxides
YU231769A (en) Process for preparing pyrindol derivatives
YU298769A (en) Process for preparing omega-cyanoalkylcarbamyl-benzimidazoles
YU34401B (en) Process for preparing novel thioureido-benzenes
YU223769A (en) Process for preparing novel 4-cyano-4-phenyl-amino-cyclohexanes
YU271675A (en) Process for obtaining hexahydro-1h-azepines
YU188969A (en) Process for preparing corticoid-21-mono-phospahtes
YU80969A (en) Process for preparing 1-alkylphenyl-sulfonyl-3-camphoryl-(or-bornyl)-carbamide derivatives
YU297679A (en) Process for preparing new isothiocyanodiphenylamines
YU34273B (en) Process for preparing novel amino-dihalo-phenyl-ethylamines
YU131369A (en) Process for preparing 1-benzyl-3-3dimethylaminopropoxy-1h--indazole
YU1469A (en) Process for preparing delta-carboxybenzyl-penicillin
YU33658B (en) Process for preparing p-hydroxybutyrophenones
ZM14468A1 (en) Process for preparing anhydrides
YU69369A (en) Process for preparing novel substituted 3-amino-4-halo-sydnone-imines
HU177719B (en) Process for preparing bis-/4-hidroxymethyl-5-hydroxy-6-methyl-pyridyl-3-methyl/-disulfide-dihydrochloride-dihydrate
YU34137B (en) Process for preparing steroide-esters
IL32822A0 (en) Process for preparing buquinolate
PH10326A (en) Process for preparing 1-alkyl-2-aminomethylpyrrolidines
YU34394B (en) Process for preparing substituted naphtoquinones
IL31884A0 (en) Process for preparing tobacco